Mortality Risk Associated With Truncating Founder Mutations in Titin
M. Jansen(Utrecht University), Dennis Dooijes(Utrecht University), Amber Ummels(Utrecht University), Arjan C. Houweling(ERN GUARD-Heart), Michelle Michels(Erasmus MC), Marja W. Wessels(Erasmus MC), Paula J.T.M. Helderman-van den Enden(Maastricht University), Annette F. Baas(University Medical Center Utrecht), Folkert W. Asselbergs(Health Data Research UK), Jan D.H. Jongbloed(University Medical Center Groningen), Eric A. M. Hennekam(University Medical Center Utrecht), Ronald H. Lekanne Deprez(Erasmus University Rotterdam), Edgar T. Hoorntje(University Medical Center Groningen), Maarten P. van den Berg(Regions Hospital), Marjon A. van Slegtenhorst(Erasmus MC), Daniela Q.C.M. Barge‐Schaapveld(Leiden University), Eric J.G. Sijbrands(Erasmus MC), J. Peter van Tintelen(Utrecht University), Hans Kristian Ploos van Amstel(University Medical Center Utrecht), Karin Y. van Spaendonck‐Zwarts(Amsterdam UMC Location Vrije Universiteit Amsterdam), Arthur van den Wijngaard(Maastricht University Medical Centre), Arthur A.M. Wilde(Amsterdam Neuroscience)
Cited by 10
Related Papers
2023 ESC Guidelines for the management of cardiomyopathies
|European Heart Journal|2023|2.3k
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk
|Nature|2011|2.1k
Genotype-Phenotype Correlation in the Long-QT Syndrome
|Circulation|2001|1.8k
HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies
|Heart Rhythm|2011|1.5k
Genome-wide association study of blood pressure and hypertension
|Nature Genetics|2009|1.4k